Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
NeuroPace (NASDAQ:NPCE) reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
NeuroPace beat estimated earnings by 26.0%, reporting an EPS of $-0.23 versus an estimate of $-0.31.
Revenue was up $5.22 million from the same period last year.
Last quarter the company beat on EPS by $0.13 which was followed by a 2.0% drop in the share price the next day.
Here's a look at NeuroPace's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.41 | -0.46 | -0.46 | -0.49 |
EPS Actual | -0.28 | -0.36 | -0.41 | -0.45 |
Revenue Estimate | 14.22M | 12.62M | 12.17M | 12.40M |
Revenue Actual | 16.43M | 16.51M | 14.47M | 12.79M |
To track all earnings releases for NeuroPace visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NPCE